Release Date: 27/05/13 17:15 Summary: Rights Issue Prospectus Price Sensitive: No Download Document 1.3MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%